AIM
MRNS

Assured Investment Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Assured Investment Management’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-3,070
Closed -$47K – 1361
2018
Q1 		$47K Buy
+3,070
New +$73.1K ﹤0.01% 1089

Other funds holding MRNS

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TBC
Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Assured Investment Management's MRNS Position: Q2 2018 in Review

Assured Investment Management sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2018, closing a stake of 3,070 shares — an estimated $47K sold.

Assured Investment Management first reported a position in MRNS in Q1 2018 and held it in 1 quarter. The position peaked at $47K in Q1 2018. 73 funds tracked by Wall St. Rank hold MRNS as of Q2 2018.

  • Assured Investment Management reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2018 after selling out during the quarter.
  • Assured Investment Management sold 3,070 Marinus Pharmaceuticals, Inc shares in Q2 2018, an estimated $47K.
  • Assured Investment Management first reported a position in Marinus Pharmaceuticals, Inc in Q1 2018 and held it in 1 quarter.
  • Assured Investment Management's Marinus Pharmaceuticals, Inc position peaked at $47K in Q1 2018.
  • 73 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2018.

Based on Assured Investment Management's 13F filing for Q2 2018, filed 13 Aug 2018.